SouthState Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,442
Closed -$2.2M 242
2020
Q1
$2.2M Buy
12,442
+403
+3% +$75.9K 0.33% 78
2019
Q4
$2.3M Buy
12,039
+996
+9% +$180K 0.26% 92
2019
Q3
$1.86M Sell
11,043
-4,544
-29% -$740K 0.23% 100
2019
Q2
$2.61M Buy
15,587
+53
+0.3% +$7.34K 0.3% 87
2019
Q1
$2.27M Buy
15,534
+493
+3% +$71.5K 0.23% 100
2018
Q4
$2.01M Sell
15,041
-15,402
-51% -$2.52M 0.23% 102
2018
Q3
$5.8M Buy
30,443
+8,521
+39% +$1.57M 0.6% 58
2018
Q2
$3.65M Buy
21,922
+75
+0.3% +$12K 0.41% 79
2018
Q1
$3.68M Buy
21,847
+6,879
+46% +$1.15M 0.42% 77
2017
Q4
$2.45M Sell
14,968
-1,360
-8% -$244K 0.26% 97
2017
Q3
$3.35K Buy
16,328
+541
+3% +$126K 0.37% 80
2017
Q2
$3.84M Buy
15,787
+1,885
+14% +$443K 0.49% 70
2017
Q1
$3.32M Buy
13,902
+6,024
+76% +$1.4M 0.43% 79
2016
Q4
$1.65M Buy
7,878
+1,267
+19% +$262K 0.24% 107
2016
Q3
$1.52M Buy
6,611
+2,263
+52% +$553K 0.23% 107
2016
Q2
$1M Buy
+4,348
New +$1M 0.15% 127

Other funds holding AGN

SouthState Corp's AGN Position: Q2 2020 in Review

SouthState Corp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 12,442 shares — an estimated $2.2M sold.

SouthState Corp first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $5.8M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • SouthState Corp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • SouthState Corp sold 12,442 Allergan plc shares in Q2 2020, an estimated $2.2M.
  • SouthState Corp first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • SouthState Corp's Allergan plc position peaked at $5.8M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on SouthState Corp's 13F filing for Q2 2020, filed 11 Aug 2020.